{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:10:05Z","timestamp":1743138605319,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":10,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071627273"},{"type":"electronic","value":"9781071627280"}],"license":[{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2728-0_13","type":"book-chapter","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T13:04:32Z","timestamp":1664024672000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cyclic AMP Assay Using Human Cannabinoid CB2 Receptor-Transfected Cells"],"prefix":"10.1007","author":[{"given":"Pietro","family":"Marini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Cascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger G.","family":"Pertwee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,25]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee RG, Howlett AC, Abood ME et al (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588\u2013631","journal-title":"Pharmacol Rev"},{"key":"13_CR2","first-page":"1045","volume":"57","author":"W Gonsiorek","year":"2000","unstructured":"Gonsiorek W, Lunn C, Fan X et al (2000) Endocannabinoid 2-arachidonoyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol 57:1045\u20131050","journal-title":"Mol Pharmacol"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"31532","DOI":"10.1074\/jbc.M111.237990","volume":"286","author":"R Yang","year":"2011","unstructured":"Yang R, Fredman G, Krishnamoorthy S et al (2011) Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals. J Biol Chem 286:31532\u201331541","journal-title":"J Biol Chem"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/1087057108327329","volume":"14","author":"D McGuinness","year":"2009","unstructured":"McGuinness D, Malikzay A, Visconti R et al (2009) Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay. J Biomol Screen 14:49\u201358","journal-title":"J Biomol Screen"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1476-5381.2009.00154.x","volume":"158","author":"I Mancini","year":"2009","unstructured":"Mancini I, Brusa R, Quadrato G et al (2009) Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242. Br J Pharmacol 158:382\u2013391","journal-title":"Br J Pharmacol"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/j.1476-5381.2011.01503.x","volume":"165","author":"D Bolognini","year":"2012","unstructured":"Bolognini D, Cascio MG, Parolaro D et al (2012) AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor. Br J Pharmacol 165:2561\u20132574","journal-title":"Br J Pharmacol"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2174\/1570159X15666170724104305","volume":"16","author":"C Rapino","year":"2018","unstructured":"Rapino C, Tortolani D, Scipioni L, Maccarrone M (2018) Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative diseases. Curr Neuropharmacol 16:959\u2013970","journal-title":"Curr Neuropharmacol"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4155\/ppa-2021-0002","volume":"10","author":"B Brennecke","year":"2021","unstructured":"Brennecke B, Gazzi T, Atz K et al (2021) Cannabinoid receptor type 2 ligands: an analysis of granted patents since 2010. Pharm Pat Anal 10:111\u2013163","journal-title":"Pharm Pat Anal"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bph.12191","volume":"169","author":"P Marini","year":"2013","unstructured":"Marini P, Cascio MG, King A et al (2013) Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors. Br J Pharmacol 169:887\u2013899","journal-title":"Br J Pharmacol"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1016\/0006-2952(93)90216-J","volume":"45","author":"AJ Morgan","year":"1993","unstructured":"Morgan AJ, Murray KJ, Chaliss RA (1993) Comparison of the effect of isobutylmethylxanthine and phosphodiesterase-selective inhibitors on cAMP levels in SH-SY5Y neuroblastoma cells. Biochem Pharmacol 45:2373\u20132380","journal-title":"Biochem Pharmacol"}],"container-title":["Methods in Molecular Biology","Endocannabinoid Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2728-0_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T13:12:50Z","timestamp":1664025170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2728-0_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,25]]},"ISBN":["9781071627273","9781071627280"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2728-0_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022,9,25]]},"assertion":[{"value":"25 September 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}